Drug development is aiming to move from managing disease to correcting it through RNA and gene-editing therapies. But ...
But delivering these treatments safely and precisely to the right cells remains a major hurdle—especially in hard-to-target organs like the brain and kidneys. Now, researchers led by a University of ...
The GPT-Rosalind model is designed to accelerate biological research and drug discovery. View on euronews ...
The company announced a new name and an effort to convert to an AI computing power business.
An emerging type of artificial intelligence, known as "agentic" AI, seems to do everything that biomedical scientists do—and ...
White House Chief of Staff Susie Wiles plans to meet with Anthropic CEO Dario Amodei to discuss the company's new AI model, ...
Wildfires used to die down and even stop at night with cooler temperatures and increased humidity. But a study released ...
HIV-1 envelope glycoprotein (Env), a gp120–gp41 trimer, undergoes coordinated conformational changes that drive membrane fusion and allow immune evasion by transiently concealing ...
The startup that claims to have developed the first usable solid-state batteries says the Verge TS Pro is the ...
Rich Walker has been at Shadow Robot since long before it was a company, working initially on software and systems ...
Major banks are reportedly upset with Coinbase over the CLARITY Act. Explore the brewing tensions in the financial sector.
At ABBYY Ascend 2026, CEO Ulf Persson unveils how the company's Document AI platform is evolving to meet current needs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results